European Commission Approves ORENCIA in Combination with Methotrexate for Earlier Use as First-Line Biologic after DMARD Inadequate Response for the Treatment of Rheumatoid Arthritis - Drugs.com MedNews

Links shared publicly online about this topic.

  • 1,037
    total visits

European Commission Approves ORENCIA in Combination with Methotrexate for Earlier Use as First-Line Biologic after DMARD Inadequate Response for the Treatment of Rheumatoid Arthritis - Drugs.com MedNews

drugs.com —

European Commission Approves ORENCIA in Combination with Methotrexate for Earlier Use as First-Line Biologic after DMARD Inadequate Response for the Treatment o

View full resource at drugs.com

Tags: Crohn's Disease Medication, Arthritis, Rheumatoid Arthritis, Rheumatoid Arthritis Medication, Rheumatrex, Trexall, Folex PFS, Orencia

  • Share

Most Recently Shared on July 8, 2010 at 10:40 am By:

RA_Wisdom OrganizedWisdom RA

European Commission Approves ORENCIA in Combination with Methotrexate for Earlier Use as First-Line Biologic after... http://bit.ly/annWwg

2 years ago...

Reply

Retweet

Favorite

Advertisement